Abstract
Advanced liver diseases represent a significant challenge to global public health, accounting for approximately 2 million deaths annually. In advanced stages, these pathologies irreversibly compromise liver function, making liver transplantation the only therapeutic alternative capable of prolonging patients' survival. Prioritization on the transplant waiting list is currently based on th…